Early cytomegalovirus reactivation is associated with a poorer outcome after an alemtuzumab-based reduced-intensity conditioning allogeneic stem cell transplant

被引：0
|
作者：
Noriega, V. [1 ]
Cutino-Moguel, T. [1 ]
Zuckerman, M. [1 ]
Potter, V. [1 ]
Barabino, L. [1 ]
Raj, K. [1 ]
McLornan, D. [1 ]
de Lavallade, H. [1 ]
Devereux, S. [1 ]
Marsh, J. [1 ]
Sudhanva, M. [1 ]
Mufti, G. [1 ]
Pagliuca, A. [1 ]
机构：
[1] Kings Coll Hosp, London, England
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S299 / S300
页数：2
相关论文
共 50 条
  • [31] Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome
    Talarn, Carme
    Urbano-Ispizua, Alvaro
    Martino, Rodrigo
    Antonio Perez-Simon, Jose
    Batlle, Montserrat
    Herrera, Concepcion
    Granell, Miquel
    Gaya, Anna
    Torrebadell, Montserrat
    Fernandez-Aviles, Francesc
    Aymerich, Marta
    Marin, Pedro
    Sierra, Jorge
    Montserrat, Emili
    HAEMATOLOGICA, 2007, 92 (12) : 1655 - 1663
  • [32] CMV infection and disease after allogeneic stem cell transplantation with reduced-intensity conditioning
    Avetisyan, G.
    Hagglund, H.
    Hassan, Z.
    LeBlanc, K.
    Mattsson, J.
    Ringden, O.
    Winiarski, J.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S241 - S242
  • [33] Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens
    M Jiménez
    G Ercilla
    C Martínez
    Leukemia, 2007, 21 : 1628 - 1637
  • [34] Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens
    Jimenez, M.
    Ercilla, G.
    Martinez, C.
    LEUKEMIA, 2007, 21 (08) : 1628 - 1637
  • [35] Cytomegalovirus infection and disease:: differences between allogeneic myeloablative stem cell transplantation and reduced-intensity conditioning
    Yañez, L
    Bermudez, A
    Insunza, A
    Colorado, M
    Ruiz, M
    Conde, E
    Baro, J
    Iriondo, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S179 - S179
  • [36] HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning
    Mead, Adam J.
    Thomson, Kirsty J.
    Morris, Emma C.
    Mohamedbhai, Sajir
    Denovan, Shari
    Orti, Guillermo
    Fielding, Adele K.
    Kottaridis, Panagiotis D.
    Hough, Rachael
    Chakraverty, Ronjon
    Linch, David C.
    Mackinnon, Stephen
    Peggs, Karl S.
    BLOOD, 2010, 115 (25) : 5147 - 5153
  • [37] Transplantation tolerance in allogeneic stem cell transplantation with reduced-intensity conditioning
    Laylor, R
    Dyson, P
    Dewchand, H
    Simpson, E
    Dazzi, F
    BONE MARROW TRANSPLANTATION, 2004, 33 : S74 - S75
  • [38] Reduced-intensity conditioning allogeneic stem cell transplantation for multiple myeloma
    Garcia, A
    Sureda, A
    Martino, R
    Valcarcel, D
    Brunet, S
    BONE MARROW TRANSPLANTATION, 2005, 35 : S200 - S200
  • [39] Results of alemtuzumab-based reduced-intensity allogeneic transplantation for advanced chronic lymphocytic leukemia: A BSBMT study
    Delgado, J
    Thomson, K
    Russell, N
    Ewing, J
    Stewart, W
    Cook, G
    Devereux, S
    Lovell, R
    Chopra, R
    Mackinnon, S
    Milligan, D
    BLOOD, 2005, 106 (11) : 813A - 813A
  • [40] Results of alemtuzumab-based reduced-intensity allogeneic transplantation for advanced chronic lymphocytic leukaemia: a BSBMT study
    Lovell, R
    Delgado, J
    Thomson, K
    Russell, N
    Ewing, J
    Stewart, W
    Marks, D
    Cook, G
    Devereux, S
    Chopra, R
    Mackinnon, S
    Milligan, D
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 66 - 67
12345